Skip to main content

Buprenorphine Prescribing by Nurse Practitioners, Physician Assistants and Physicians After CARA 2016

Description
Investigates the differences in buprenorphine prescribing patterns among nurse practitioners (NPs), physician assistants (PAs) and physicians in Medicaid following implementation of the Comprehensive Addiction and Recovery Act (CARA) addressing opioid use disorder (OUD). Retail pharmacy claims from July 2017 to June 2018 were analyzed to identify prescriber type, number of patients, payer type, rural and urban differences, and Medicaid trends for FDA-approved buprenorphine drugs for the treatment of OUD.
Author(s)
Rekha Varghese, Karin Johnson, Bo Feng, et al.
Date
04/2019
Type
Document
Organizations
IMPAQ International, LLC, Medicaid and CHIP Payment and Access Commission
Tagged as
Legislation and regulations · Medicaid · Nurse practitioners and other advanced practice registered nurses · Pharmacy and prescription drugs · Physician assistants · Physicians · Prescription drug abuse · Scope of practice · Statistics and data